Latest filing published 26 Feb 2026 for Novonesis (Novozymes A/S), €904k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Ester Baiget: trading record in brief
All filings by Ester Baiget on record concern Novonesis (Novozymes A/S). The record holds 6 filings, for trades running from 2 September 2020 to 26 February 2026.
The open-market record is one-sided, with 2 purchases worth €510k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Most recently, on 26 February 2026, the filings show a transaction worth €904k in Novonesis (Novozymes A/S). The last insider purchase was made public on 27 January 2023, 1,381 days ago. Publication is fast: at least half of the trades appear on Finanstilsynet DK on the same day. Under the Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from Finanstilsynet DK. Past trades are no guide to future returns.
Companies and markets linked to Ester Baiget
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 18,337 shares@ DKK 368.500.1% of flowShareOutside a trading venueISIN DK0060336014DK:1422788
- 12,120 shares@ DKK 428.100.0% of flowShareOutside a trading venueISIN DK0060336014DK:1345683
- 14,923 shares@ DKK 371.600.1% of flowShareOutside a trading venueISIN DK0060336014DK:1272505
- 3,674 shares@ DKK 347.000.0% of flowShareCopenhagen Stock ExchangeISIN DK0060336014DK:1203493Canonical exit: 27 Apr 2023 (T+90)
- 10,707 shares@ DKK 348.300.0% of flowShareOutside a trading venueISIN DK0060336014DK:1203468
- 6,800 shares@ DKK 371.08640.0% of flowShareISIN DK0060336014DK:953995Canonical exit: 1 Dec 2020 (T+90)
6 of 6 declarations